Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Tumefactive demyelinating lesions as a first clinical event: Clinical, imaging, and follow-up observations.
Equivalence of Glatiramer Acetate Generics With Branded Glatiramer Acetate in Efficacy and Cost for the Treatment of Multiple Sclerosis.
[NLRP3 inflammasome and multiple sclerosis/EAE].
Biomechanical analysis of spasticity treatment in patients with multiple sclerosis.
The progress of cognitive decline in newly diagnosed MS patients.
Ultra-high-field MR imaging in multiple sclerosis.
Multifocal visual evoked potential in optic neuritis, ischemic optic neuropathy and compressive optic neuropathy.
[110th Scientific Meeting of the Japanese Society of Internal Medicine: Educational lecture: 11. Multiple sclerosis (MS) and neuromyelitis optica (NMO)].
A MS-lesion pattern discrimination plot based on geostatistics.
ECL1i, d(LGTFLKC), a novel, small peptide that specifically inhibits CCL2-dependent migration.
Mode of action and clinical studies with fumarates in multiple sclerosis.
Wheelchair design for people with neuromuscular disability.
Sex-specific differences in retinal nerve fiber layer thinning after acute optic neuritis.
Overexpression of CD44 in Neural Precursor Cells Improves Trans- Endothelial Migration and Facilitates Their Invasion of Perivascular Tissues In Vivo.
Epstein-Barr virus antibodies and vitamin D in prospective multiple sclerosis biobank samples.
Sphingosine-1-Phosphate Receptors in the Central Nervous and Immune Systems.
Non-Local Means Inpainting of MS Lesions in Longitudinal Image Processing.
Treatment adherence and other patient-reported outcomes as cost determinants in multiple sclerosis: a review of the literature.
Development of Gene Transfer for Induction of Antigen-specific Tolerance.
Lower urinary tract symptoms associated with neurological conditions: Observations on a clinical sample of outpatients neurorehabilitation service.
Extending Treatment Up To Eight Weeks With Infusion Medication Shown Safe and Effective in Patients with Multiple Sclerosis
Propentofylline reverses delayed remyelination in streptozotocin-induced diabetic rats.
Mesenchymal stem cells do not exert direct beneficial effects on CNS remyelination in the absence of the peripheral immune system.
Optical Coherence Tomography Reveals Distinct Patterns of Retinal Damage in Neuromyelitis Optica and Multiple Sclerosis.
Neuromyelitis optica in a Ugandan woman: a case report.
Pages
« first
‹ previous
…
510
511
512
513
514
515
516
517
518
…
next ›
last »